4/23/2013 9:28:37 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
WESTBROOK, Maine, April 23, 2013 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), today reported that revenues for the first quarter of 2013 increased 3% to $332.1 million, from $322.7 million for the first quarter of 2012. Organic revenue growth(1) was also SHY3%. Earnings per diluted share ("EPS") for the quarter ended March 31, 2013 increased 12% to $0.81, compared to $0.72 for the same period in the prior year. First quarter 2013 EPS includes the retroactive extension of the federal research and development tax credit, which added $0.05 to EPS, and a $4.1 million charge resulting from a third-party service provider's bankruptcy, which reduced EPS by $0.05.
Help employers find you! Check out all the jobs and post your resume.
comments powered by